GSK plc Files Director/PDMR Shareholding Report
Ticker: GSK · Form: 6-K · Filed: 2026-04-09T12:38:47-04:00
Sentiment: neutral
Topics: insider-filing, director-shareholding, 6-K
TL;DR
GSK filed a 6-K on director shareholdings - check for insider moves.
AI Summary
On April 9, 2026, GSK plc filed a Form 6-K with the SEC, reporting a Director/PDMR Shareholding. The filing details transactions related to director and PDMR (Persons Discharging Managerial Responsibility) shareholdings within the company.
Why It Matters
This filing provides transparency into the share ownership and transactions of key company personnel, which can be an indicator of insider confidence or changes in management's stake.
Risk Assessment
Risk Level: low — This is a routine disclosure of director and PDMR shareholdings, not indicative of significant new risks.
Key Players & Entities
- GSK plc (company) — Filer of the report
- 0001131399 (company) — CIK number for GSK plc
- April 9, 2026 (date) — Filing date and period of report
FAQ
What type of document is this 6-K filing?
This is a Form 6-K, a Report of foreign issuer, specifically detailing Director/PDMR Shareholding.
Who is the filer of this report?
The filer is GSK plc, with CIK number 0001131399.
When was this filing made?
The filing date was April 9, 2026.
What is the primary subject of the document attached to this 6-K?
The document is titled 'DIRECTOR/PDMR SHAREHOLDING'.
What are the business and mailing addresses for GSK plc listed in this filing?
Both the mailing and business addresses are listed as 79 NEW OXFORD STREET LONDON United Kingdom WC1A 1DG.
From the Filing
EDGAR Filing Documents for 0001654954-26-003371 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: SEC Accession No. 0001654954-26-003371 Filing Date 2026-04-09 Accepted 2026-04-09 12:38:47 Documents 1 Period of Report 2026-04-09 Document Format Files Seq Description Document Type Size 1 DIRECTOR/PDMR SHAREHOLDING a8641z.htm 6-K 38122 Complete submission text file 0001654954-26-003371.txt 39377 Mailing Address 79 NEW OXFORD STREET LONDON United Kingdom WC1A 1DG Business Address 79 NEW OXFORD STREET LONDON United Kingdom WC1A 1DG 44 20 8047 5000 GSK plc (Filer) CIK : 0001131399 (see all company filings) EIN. : 000000000 | State of Incorp.: X0 Type: 6-K | Act: 34 | File No.: 001-15170 | Film No.: 26850636 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)